Impact of a single session of hyperbaric oxygen... (2025 study) Skip to main content
Clinical Study Frontiers in ophthalmology 2025

Impact of a single session of hyperbaric oxygen therapy on the healthy retina.

Demir N, Sumen SG, Kayhan B, Frontiers in ophthalmology, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers tested whether a single hyperbaric oxygen therapy (HBOT) session changes the healthy retina, using eye scans and electrical retina tests before and after treatment.

What They Found

This clinical study examined 20 patients undergoing HBOT for sensorineural hearing loss or avascular necrosis, measuring retinal function and structure before and within 24 hours after a single session, and found a statistically significant change in one electrical retinal measure along with thickening in one retinal layer. The scotopic 0.01 ERG b-wave amplitude differed significantly before versus after HBOT (p equals 0.029). The retinal pigment epithelium in the 3-mm nasal subfield of the ETDRS grid showed statistically significant thickening after the session (p equals 0.023). Participants averaged 43.2 years old, ranging from 18 to 66.

What This Means for Canadian Patients

For patients in Canada receiving HBOT for conditions such as sensorineural hearing loss or avascular necrosis, this study found that a single session was associated with a measurable change in rod-bipolar cell electrical activity in the retina. The abstract does not report whether this change persists, reverses, or affects vision, so its practical significance for patients is not established.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study involved only 20 patients with a single follow-up point within 24 hours, and the abstract states that further studies are needed to determine how long the observed electrophysiological changes last or whether they reverse.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 41190089
Year Published 2025
Journal Frontiers in ophthalmology

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology